Thus, overexpression of lncRNA CRNDE attenuates resistance to oxaliplatin in GC patients and improves the therapeutic efficiency of patients by decreasing the stability of SRSF6, which results in a decrease in l-type expression during SRSF6 splicing of PICALM [48]. This evidence concerns the gene SRSF6 and gastric cancer.